The 16% rise for FATE stock compares with 4% gains seen in the broader S&P 500 index. Now, is FATE stock poised to gain further? It appears so. While we believe that FATE stock is richly valued, the market potential is huge, especially in multi-billion dollar – oncology treatments. Given the current momentum in the stock, and based on our machine learning analysis of trends in the stock price over the last few years, we believe that there is an 64% chance of a rise in FATE stock over the next month (twenty one trading days). See our analysis on Fate Therapeutics Stock Chances of Rise for more details.